Otonomy, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$420Kgeneral payments (2019-2025)
$939research payments (2019-2025)
59clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| James Breitmeyer | San Diego, CA | Internal Medicine | $203,409.13 |
| Stephen Bradley | La Jolla, CA | Critical Care Medicine (Internal Medicine) | $75,250.00 |
| Jeffrey Kittrelle | San Diego, CA | Clinical Pharmacology | $74,470.00 |
| Hinrich Staecker | Kansas City, KS | $29,155.37 | |
| John Greinwald | Cincinnati, OH | Pediatric Otolaryngology | $12,248.38 |
| Dawn Mcguire | San Francisco, CA | Neurology (Psychiatry & Neurology) | $10,200.00 |
| Rick Friedman | La Jolla, CA | Otology & Neurotology | $5,791.58 |
| Seth Pransky | San Diego, CA | Pediatric Otolaryngology | $3,862.00 |
| Anthony Mikulec | St. Louis, MO | Otology & Neurotology | $2,741.67 |
| Xue Liu | Miami, FL | Otolaryngology | $1,500.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.